Dr. Abasi Ene-Obong joins the leading global entrepreneur support organisation
Endeavor has welcomed a new entrepreneur into its global network; Dr. Abasi Ene-Obong of 54gene, got selected as an Endeavor Entrepreneur on September 17, 2020.
54gene is a health technology company whose mission is to advance precision medicine capabilities in Africa through research, advanced molecular diagnostics and clinical programs.
54gene joins 10 other Endeavor Entrepreneur-led companies in Nigeria, and over 1,300 in Endeavor’s 37 markets across Africa, Latin America, Asia, Europe and North America.
Endeavor is a mission-driven organisation that is leading the global movement for high-impact entrepreneurs and their companies.
Endeavor Nigeria selects, mentors and accelerates the best high-impact entrepreneurs in the region, supporting them to scale their companies and drive economic growth.
As well as 54gene, this year, Endeavor has welcomed the founders of Daystar Power, Migo and Kobo360 into its local and global network.
Africa is home to the most genetically diverse population in the world. However, less than 3% of the continent’s genomic data is available for research purposes making it a potentially rich source of new genetic information used for medical discoveries.
54gene is solving this challenge and equalising the access to precision medicine through the advancement of the state of healthcare in Nigeria and on the continent.
This is achieved through local clinical research programs and advanced molecular diagnostics.
Eloho Omame, Managing Director & CEO of Endeavor in Nigeria, commented:
“54gene is a critical part of the continent’s push to equalize access to precision medicine for millions of Africans.
The rapid pace at which the company has scaled over the past year is testament to Dr. Abasi Ene-Obong’s leadership, his drive and talented team.
He is an inspiration to other high-impact entrepreneurs in Nigeria and we are thrilled to welcome him into the Endeavor network.”
Since launching in 2019, 54gene has scaled its operations in generating novel insights in human genetics research that will lead to high impact health discoveries.
At the onset of the COVID-19 pandemic in Nigeria, 54gene raised funds to increase the country’s testing capacity and launched mobile laboratories across 5 Nigerian states.
The company has raised $21 million in investment and also launched the African Centre for Translational Genomics (ACTG) to fund the study of Non-Communicable Diseases in 100,000 Nigerians.
In September of this year, the company announced a partnership with Illumina to establish a world class genomics facility in Lagos, Nigeria, which will help expand its sequencing-based research and molecular diagnostics offering.
Dr. Abasi Ene-Obong, CEO and Founder of 54gene, says:
“It is an absolute honour to get selected as an Endeavor entrepreneur. We started 54gene to significantly improve the inclusion of African populations in global genomics research and I am glad to see our work getting recognised.
Our mission is to continue driving innovation and change in research and I look forward to the opportunities that arise as a result of getting support by the global Endeavor network in expanding 54gene’s impact globally.”
Dr. Abasi Ene-Obong was successfully selected as part of a cohort of 9 entrepreneurs from 6 markets.
With the recent addition of 54gene, Endeavor Nigeria now supports 17 entrepreneurs who lead 11 scale-up stage companies in Nigeria, spanning life sciences, fintech, renewable energy, entertainment, logistics and retail.
Featured Image: Dr. Abasi Ene-Obong, Founder and CEO of 54gene
Don’t miss important articles during the week. Subscribe to cfamedia weekly digest for updates.
